目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Application
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT
6.1. Overview
6.2. Endoscopes
6.3. Endotherapy Devices
6.3.1. Catheters
6.3.2. Stents
6.3.3. Balloons
6.3.4. Guiding Wires
6.3.5. Others
6.4. Imaging Devices
6.5. Energy Devices
7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PROCEDURE
7.1. Overview
7.2. Biliary Sphincterotomy
7.3. Biliary Stenting
7.4. Biliary Dilatation
7.5. Pancreatic Duct Stenting
7.6. Others
8. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION
8.1. Overview
8.2. Bile Duct
8.3. Pancreas
8.4. Others
9. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER
9.1. Overview
9.2. Hospitals & Clinics
9.3. Ambulatory Surgical Centers
9.4. Others
10. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Endoscopic Retrograde Cholangiopancreatography Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Endoscopic Retrograde Cholangiopancreatography Market
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2021
11.8.2. Major Players R&D Expenditure. 2021
12. COMPANY PROFILES
12.1. Olympus Corporation
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Fujifilm Holdings Corproation
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. STERIS PLC
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Cook Medical
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Boston Scientific Corporation
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. CONMED Corporation
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. HOYA Group
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Q3 Medical Devices Limited
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Ambu Inc.
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Medtronic Plc
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Others
13. APPENDIX
13.1. References
13.2. Related Reports
?
LIST OF TABLES
TABLE 1 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SYNOPSIS, 2018-2030
TABLE 2 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET ESTIMATES & FORECAST, 2018-2030 (USD MILLION)
TABLE 3 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 4 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 5 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 6 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 7 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 9 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 11 US: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 12 US: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 13 US: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14 US: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 15 CANADA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 16 CANADA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 17 CANADA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18 CANADA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 1 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 2 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 3 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 4 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 5 GERMANY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6 GERMANY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 7 GERMANY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 8 GERMANY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 9 FRANCE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 10 FRANCE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 11 FRANCE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12 FRANCE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 13 ITALY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 14 ITALY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 15 ITALY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16 ITALY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 17 SPAIN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 18 SPAIN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 19 SPAIN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20 SPAIN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 21 UK: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22 UK: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 23 UK: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24 UK: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 25 REST OF EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26 REST OF EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 27 REST OF EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28 REST OF EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 33 JAPAN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34 JAPAN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 35 JAPAN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36 JAPAN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 37 CHINA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38 CHINA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 39 CHINA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40 CHINA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 41 INDIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42 INDIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 43 INDIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44 INDIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 45 AUSTRALIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46 AUSTRALIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 47 AUSTRALIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48 AUSTRALIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 49 SOUTH KOREA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50 SOUTH KOREA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 51 SOUTH KOREA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52 SOUTH KOREA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 53 REST OF ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54 REST OF ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 55 REST OF ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56 REST OF ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 57 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 59 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 61 MIDDLE EAST: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62 MIDDLE EAST: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 63 MIDDLE EAST: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64 MIDDLE EAST: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 65 AFRICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66 AFRICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 67 AFRICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68 AFRICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
TABLE 69 LATIN AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70 LATIN AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 71 LATIN AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72 LATIN AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018-2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET
FIGURE 4 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY PRODUCT, 2021
FIGURE 5 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY PROCEDURE, 2021
FIGURE 6 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY APPLICATION, 2021
FIGURE 7 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY END USER, 2021
FIGURE 8 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY REGION, 2021
FIGURE 9 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 10 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 11 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 12 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY REGION, 2021
FIGURE 13 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: COMPANY SHARE ANALYSIS (%), 2021
FIGURE 14 OLYMPUS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 OLYMPUS CORPORATION: SWOT ANALYSIS
FIGURE 16 FUJIFILM HOLDINGS CORPROATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 FUJIFILM HOLDINGS CORPROATION: SWOT ANALYSIS
FIGURE 18 STERIS PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 STERIS PLC: SWOT ANALYSIS
FIGURE 20 COOK MEDICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 COOK MEDICAL: SWOT ANALYSIS
FIGURE 22 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
FIGURE 24 CONMED CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 CONMED CORPORATION: SWOT ANALYSIS
FIGURE 26 HOYA GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 HOYA GROUP: SWOT ANALYSIS
FIGURE 28 Q3 MEDICAL DEVICES LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 Q3 MEDICAL DEVICES LIMITED: SWOT ANALYSIS
FIGURE 30 AMBU INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 AMBU INC.: SWOT ANALYSIS
FIGURE 32 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 MEDTRONIC PLC: SWOT ANALYSIS
